- Trials with a EudraCT protocol (4)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
4 result(s) found for: Normative influence.
Displaying page 1 of 1.
EudraCT Number: 2016-002635-15 | Sponsor Protocol Number: 15-06 | Start Date*: 2016-07-28 |
Sponsor Name:VU Medical Center | ||
Full Title: Study to Identify Factors associated with Resilience to Clinical Dementia at Old Age | ||
Medical condition: The protective factors of Alzheimer's disease in subjects aged 90 years and older | ||
Disease: | ||
Population Age: Elderly | Gender: Male, Female | |
Trial protocol: NL (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2006-003991-37 | Sponsor Protocol Number: AGO/2006/009 | Start Date*: 2006-12-13 | |||||||||||
Sponsor Name:University Hospital Gent | |||||||||||||
Full Title: Trial of beta blocker therapy (atenolol) vs. angiotensin II receptor blocker therapy (losartan) in individuals with Marfan syndrome | |||||||||||||
Medical condition: Marfan syndrome | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-002745-38 | Sponsor Protocol Number: GEIS-30 | Start Date*: 2012-10-22 | ||||||||||||||||
Sponsor Name:Grupo Español de Investigación en Sarcomas | ||||||||||||||||||
Full Title: Phase II Clinical Trial of Pazopanib to evaluate the activity and tolerability in patients with advanced and/or metastatic liposarcoma who have relapsed following standard therapies or for whom no ... | ||||||||||||||||||
Medical condition: Advanced and/or metastatic liposarcoma | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Completed) DE (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2008-008922-55 | Sponsor Protocol Number: GEIS20 | Start Date*: 2009-06-04 | |||||||||||
Sponsor Name:Grupo Español de Investigación en Sarcomas | |||||||||||||
Full Title: ENSAYO FASE II ALEATORIZADO, ABIERTO, MULTICÉNTRICO Y PROSPECTIVO DE DOXORRUBICINA vs TRABECTEDINA Y DOXORRUBICINA EN PRIMERA LÍNEA DE PACIENTES CON SARCOMA DE PARTES BLANDAS AVANZADOS NO OPERABLES... | |||||||||||||
Medical condition: Sarcoma de partes blandas avanzados no operables y/o metastásicos | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Prematurely Ended) PT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
